CHRISTOPHER P LARSEN

Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology LITTLE ROCK, AR NPI 1447434840

General Payments — all program years on this page

$28,482.39

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 13
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $11,986.21 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $9,525.002
Travel and Lodging $1,582.233
Food and Beverage $878.984

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $6,352.676
CALLIDITAS THERAPEUTICS US INC. $5,633.543

By program year

Program yearAmountRecords
2018 $11,746.183
2020 $4,750.001
2024 $11,986.219

Records — PY2024 (9)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087147888 Novartis Pharmaceuticals Corporation $88.24 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087155896 Novartis Pharmaceuticals Corporation $290.75 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087155920 Novartis Pharmaceuticals Corporation $207.28 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087155922 Novartis Pharmaceuticals Corporation $5,025.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1087155924 Novartis Pharmaceuticals Corporation $601.41 11/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1087155940 Novartis Pharmaceuticals Corporation $139.99 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141523439 CALLIDITAS THERAPEUTICS US INC. $773.54 09/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141523441 CALLIDITAS THERAPEUTICS US INC. $360.00 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141524724 CALLIDITAS THERAPEUTICS US INC. $4,500.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.